PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC is reminding investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a pending securities class action against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT), pending in the U.S. District Court for the Northern District of California. The suit alleges Procept and certain executives failed to disclose that U.S. handpiece sales materially exceeded procedures throughout the class period, ultimately resulting in cumulative excess field inventory of more than 10,000 units.
Key figures
- Class period
- February 28, 2024 to February 25, 2026
- Revenue guidance miss
- tens of millions of dollars
- Two day stock decline
- more than 18%
- Share price 2026 02 25
- 27.84
- Share price 2026 02 27
- 22.69
- Lead plaintiff deadline
- 2026-09-22
- Sequential unit decline
- nearly 30%
- Us handpiece units q3 2025
- 13225
- Us handpiece units q4 2025
- 9400
- Excess field inventory units
- 10000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.